
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
Lu Liu, Lijun Wang, Lihong Zhao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 37
Lu Liu, Lijun Wang, Lihong Zhao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E. Chaft, Filiz Öezkan, Mark G. Kris, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2155-2161
Open Access | Times Cited: 163
Jamie E. Chaft, Filiz Öezkan, Mark G. Kris, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2155-2161
Open Access | Times Cited: 163
Diversity of immune checkpoints in cancer immunotherapy
Zhangyan Guo, Rui Zhang, Angang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Zhangyan Guo, Rui Zhang, Angang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Advanced Cell Therapies for Glioblastoma
Guangwen Wang, Wenshi Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Guangwen Wang, Wenshi Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Barbara Seliger, Ulrike Koehl
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Barbara Seliger, Ulrike Koehl
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context
Valentine Wang, Barbara Savoldo, J. Guimarães, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Valentine Wang, Barbara Savoldo, J. Guimarães, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Inhibitory and Activating Natural Killer Receptors in Humans: A Historical Overview
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
Springer eBooks (2025), pp. 1-51
Closed Access
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
Springer eBooks (2025), pp. 1-51
Closed Access
The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy
Jia Mao, Ying Feng, Xiaofeng Zhu, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1213-1213
Open Access | Times Cited: 12
Jia Mao, Ying Feng, Xiaofeng Zhu, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1213-1213
Open Access | Times Cited: 12
Cancer and Secretomes: HLA-G and Cancer Puzzle
Figen Abatay Sel, Fatma Savran Oğuz
Advances in experimental medicine and biology (2025)
Closed Access
Figen Abatay Sel, Fatma Savran Oğuz
Advances in experimental medicine and biology (2025)
Closed Access
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer
Jinlong Tian, Yanlei Li, Tong Yu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jinlong Tian, Yanlei Li, Tong Yu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
Burcu Duygu, Timo I. Olieslagers, Mathijs Groeneweg, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Burcu Duygu, Timo I. Olieslagers, Mathijs Groeneweg, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes
Huihui Xu, Huili Wang, Tong-Jin Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Huihui Xu, Huili Wang, Tong-Jin Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Human leukocyte antigen and tumor immunotherapy (Review)
Da-Hua Liu, Fei-Fei Mou, Min An, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 10
Da-Hua Liu, Fei-Fei Mou, Min An, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 10
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6665-6665
Open Access | Times Cited: 19
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6665-6665
Open Access | Times Cited: 19
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009774-e009774
Open Access | Times Cited: 2
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009774-e009774
Open Access | Times Cited: 2
IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis
Hui Zheng, Xiaolin Guan, Xin Meng, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Hui Zheng, Xiaolin Guan, Xin Meng, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos
Sophie M. Morgani, Jie Su, Jennifer Nichols, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 12
Sophie M. Morgani, Jie Su, Jennifer Nichols, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 12
Engineered cells as glioblastoma therapeutics
Aparna Ramanathan, Ian A.J. Lorimer
Cancer Gene Therapy (2021) Vol. 29, Iss. 2, pp. 156-166
Open Access | Times Cited: 11
Aparna Ramanathan, Ian A.J. Lorimer
Cancer Gene Therapy (2021) Vol. 29, Iss. 2, pp. 156-166
Open Access | Times Cited: 11
The association between genetic variants at 3’-UTR and 5’-URR of HLA-G gene and the clinical outcomes of patients with leukemia receiving hematopoietic stem cell transplantation
Ding‐Ping Chen, Po‐Nan Wang, Ai‐Ling Hour, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Ding‐Ping Chen, Po‐Nan Wang, Ai‐Ling Hour, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 1
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 1
HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine
Ismael Adolf, Amany I. Almars, Nazima Dharsee, et al.
Genes & Diseases (2021) Vol. 9, Iss. 5, pp. 1220-1233
Open Access | Times Cited: 9
Ismael Adolf, Amany I. Almars, Nazima Dharsee, et al.
Genes & Diseases (2021) Vol. 9, Iss. 5, pp. 1220-1233
Open Access | Times Cited: 9
Epigenetic/genetic variations in CG‐rich elements of immune‐related genes contribute to food allergy development during childhood
Maria Kostara, Vasiliki Chondrou, V. Fotopoulos, et al.
Pediatric Allergy and Immunology (2022) Vol. 33, Iss. 6
Open Access | Times Cited: 6
Maria Kostara, Vasiliki Chondrou, V. Fotopoulos, et al.
Pediatric Allergy and Immunology (2022) Vol. 33, Iss. 6
Open Access | Times Cited: 6
Non-Classical HLA Class 1b and Hepatocellular Carcinoma
Vallì De Re, Maria Lina Tornesello, Vito Racanelli, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1672-1672
Open Access | Times Cited: 2
Vallì De Re, Maria Lina Tornesello, Vito Racanelli, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1672-1672
Open Access | Times Cited: 2
Clinical variables and genetic variants associated with perioperative anaphylaxis in Chinese Han population: A pilot study
Qi Zheng, Ye Cheng, Yu Su, et al.
World Allergy Organization Journal (2023) Vol. 17, Iss. 1, pp. 100854-100854
Open Access | Times Cited: 2
Qi Zheng, Ye Cheng, Yu Su, et al.
World Allergy Organization Journal (2023) Vol. 17, Iss. 1, pp. 100854-100854
Open Access | Times Cited: 2
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis
Roberto Littera, Andrea Perra, Michela Miglianti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Roberto Littera, Andrea Perra, Michela Miglianti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4